942 HVAD™ patients on support worldwide as of April 2026
Source: HVAD™ site reported data. Not independently confirmed or validated by Medtronic.
Underlying data provided with the permission of The Society of Thoracic Surgeons.
Copyright ©2024 The Society of Thoracic Surgeons.
1. Subjects were censored at the time of any non-death related explant.
2. Contemporary cohort included implanted HVAD™ System left ventricular assist devices following FDA approval for destination therapy in October 2017 through cessation of the sale and distribution of the device in June 2021.
3. STS Intermacs Report — North American registry data of FDA-approved durable devices implanted for treatment of advanced heart failure; current analysis is for first quarter 2026 with follow-up through March 31, 2026.
STS — Society of Thoracic Surgeons; Intermacs — Interagency Registry of Mechanically Assisted Circulatory Support; FDA — Food and Drug Administration.